Merryn Voysey

Merryn Voysey

University of Oxford

H-index: 51

Europe-United Kingdom

About Merryn Voysey

Merryn Voysey, With an exceptional h-index of 51 and a recent h-index of 46 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Vaccines and infectious disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children< 2 years of age

Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study

Evaluation of acute and convalescent antibody concentration against pneumococcal capsular polysaccharides for the diagnosis of pneumococcal infection in children with community …

Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial (preprint)

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease

Effects of two early parenting programmes on child aggression and risk for violence in Brazil: a randomised controlled trial

Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

Merryn Voysey Information

University

Position

Senior Statistician

Citations(all)

33463

Citations(since 2020)

24889

Cited By

14060

hIndex(all)

51

hIndex(since 2020)

46

i10Index(all)

106

i10Index(since 2020)

94

Email

University Profile Page

Google Scholar

Merryn Voysey Skills & Research Interests

Vaccines and infectious disease

Top articles of Merryn Voysey

Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children< 2 years of age

Vaccine

2024/2/22

Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study

The Lancet Microbe

2024/2/19

Evaluation of acute and convalescent antibody concentration against pneumococcal capsular polysaccharides for the diagnosis of pneumococcal infection in children with community …

The Pediatric Infectious Disease Journal

2024/2/1

Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial (preprint)

2024

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease

Nature Communications

2024/4/22

Effects of two early parenting programmes on child aggression and risk for violence in Brazil: a randomised controlled trial

2024/3/19

Andrea Gonzalez
Andrea Gonzalez

H-Index: 26

Merryn Voysey
Merryn Voysey

H-Index: 33

Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi

Plos one

2024/3/1

Merryn Voysey
Merryn Voysey

H-Index: 33

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

Clinical and Experimental Immunology

2023/3/1

Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after 13-valent pneumococcal conjugate vaccine introduction: persistence of serotypes 3 and 19A …

J Infect Dis

2023/3/1

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021

Archives of disease in childhood

2023/2/1

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines–a systematic review and network meta-analysis

2023/1/14

Shuo Feng
Shuo Feng

H-Index: 9

Merryn Voysey
Merryn Voysey

H-Index: 33

Understanding COVID-19 testing behaviour in England through a sociodemographic lens (preprint)

2023

Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data

The Lancet Global Health

2023/1/1

Merryn Voysey
Merryn Voysey

H-Index: 33

Robert S Heyderman
Robert S Heyderman

H-Index: 46

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Nature medicine

2023/1

SARS-CoV-2 seroprevalence in pregnant women in Kilifi, Kenya from March 2020 to March 2022

Frontiers in Public Health

2023/12/19

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

Iscience

2023/12/15

Seroepidemiology of COVID-19 in pregnant women and their infants in Uganda and Malawi across multiple waves 2020-2022

medRxiv

2023/8/21

Merryn Voysey
Merryn Voysey

H-Index: 33

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single …

The Lancet

2022/1/1

Optimising DTwP-containing vaccine infant immunisation schedules (OptImms)—a protocol for two parallel, open-label, randomised controlled trials

Trials

2023/7/21

Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data

2023/7/1

Shuo Feng
Shuo Feng

H-Index: 9

Merryn Voysey
Merryn Voysey

H-Index: 33

See List of Professors in Merryn Voysey University(University of Oxford)

Co-Authors

academic-engine